HAL Allergy at a glance
Improving the quality of life with innovative allergy research, development and production of causal treatments for more than 50 years
HAL Allergy is a modern biopharmaceutical company with GMP certified and state-of-the-art facilities located at the Bio Science Park in Leiden, The Netherlands. Since 1959 our focus stems from the development, production and distribution of Allergen Immunotherapies for causal treatment and prevention of allergic diseases. We produce and develop innovative allergy specific immunotherapy products for causal treatment of all common allergies such as allergic rhinitis and allergic asthma caused by pollen species, house dust mites or insect venom from bee or wasp. Peanut immunotherapy is another novel therapeutic approach.
HAL Allergy focuses on the core group of allergy experts from the specialties of Ear Nose and Throat, Dermatology and Pulmonology. All of our activities are targeting to provide the best possible medical products and scientific output in order to increase quality of life for allergic patients and to serve our professional customers.
We work intensively in collaboration with our sales organizations, distributors and internationally acclaimed research institutes to identify the best possible combination of knowledge and experience.
HAL Allergy is a subsidiary of the family owned Droege Group
Droege Group (founded in 1988) is an independent advisory and investment company under full family ownership. The company acts as a specialist for tailor-made transformation programs aiming to enhance corporate value. Droege Group combines its corporate family-run structure and capital strength into a family-equity business model. The group carries out direct investments with its own equity in corporate spin-offs and medium-sized companies in ‘special situations’. With the guiding principle ‘execution – following the rules of art’, the group is a pioneer in execution-oriented corporate development. Droege Group follows a focused investment strategy based on current megatrends (knowledge, connectivity, prevention, demography, specialization, future work, shopping 4.0). Enthusiasm for quality, innovation and speed determines the company’s actions. In recent years Droege Group has successfully positioned itself in domestic and international markets and operates in 30 countries.
More information: www.droege-group.com